Chromosome 18q loss and prognosis in colorectal cancer

C - Chemistry – Metallurgy – 12 – Q

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12Q 1/68 (2006.01)

Patent

CA 2140057

We have developed procedures to examine the status of chromosome 18q with polymorphic genetic markers and DNA from formalin-fixed, paraffin- embedded tumors. Allelic loss of chromosome 18q was assessed in 145 consecutively resected stage II or III colorectal carcinomas. Among patients with stage II disease, the five-year survival rate was 93 percent in those whose tumor had no evidence of allelic loss of chromosome 18q and 54 percent in those with allelic loss; among patients with stage III disease, survival was 52 and 38 percent, respectively.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Chromosome 18q loss and prognosis in colorectal cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Chromosome 18q loss and prognosis in colorectal cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chromosome 18q loss and prognosis in colorectal cancer will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1900719

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.